Company intelligence / Profile preview

Nuviant Medical

Liege, Belgium

Ownership: Private
Development stage: Other

Overview

Nuviant Medical's lead product, the Synapse system, is a closed-loop neuromodulation platform that delivers 32 channels of stimulation while simultaneously recording neural signals.[2] The Synapse has received CE Mark approval for adjunctive alleviation therapy of movement disorder symptoms associated with Parkinson's disease.[1][2]

Therapeutic areas: Neurology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Nuviant Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuviant Medical.

Explore the full profile